<DOC>
	<DOCNO>NCT00001625</DOCNO>
	<brief_summary>Patients high blood pressure , diabetes , overweight know defect way body respond insulin . The purpose study develop good method measure way body tissue respond insulin sugar ( glucose ) . Researchers plan study four group patient . 1 . Normal volunteer 2 . Patients mild moderate high blood pressure 3 . Patients overweight 4 . Patients mild moderate diabetes control oral medication In study patient volunteer undergo two separate test design determine well insulin work body . The first test call glucose clamp test . Patients two needle place vein arm . One needle use take blood sample , needle use inject dos sugar ( glucose ) insulin . The second test call frequently sample intravenous glucose tolerance test . In test patient sugar ( glucose ) inject vein follow slow inject dose ( infusion ) insulin . Researchers periodically take blood sample test . Patients participate study directly benefit . However , information gain study may useful improve diagnosis therapy diseases diabetes , obesity , high blood pressure ( hypertension ) .</brief_summary>
	<brief_title>Methods Measuring Insulin Sensitivity</brief_title>
	<detailed_description>We hypothesize majority information need accurately estimate insulin sensitivity contain fasting insulin glucose level well insulin glucose level obtain shortly intravenous glucose load . We propose test hypothesis perform hyperinsulinemic euglycemic glucose clamp well intravenous glucose tolerance test normal volunteer group patient diabetes , hypertension , obesity ( diseases know associated insulin resistance ) . Data study use obtain estimate insulin sensitivity glucose clamp method , minimal model method , novel analysis utilizes fast peak level glucose insulin . We hope devise simple method determine insulin sensitivity vivo suitable test large population . This method require blood sample , take less one hour perform , correlate glucose clamp estimate least well minimal model method .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>INCLUSION CRITERIA : Normal Volunteers : Adults age 21 55 good general health significant underlying illness , medication , normal body mass index ( 2026 kg/m ( 2 ) ) . Obese Subjects : Adults age 21 55 good general health significant underlying illness , medication , body mass index 30 35 kg/m ( 2 ) . Hypertensive Subjects : Adults age 21 55 good general health except mild moderate hypertension ( blood pressure 140/95 170/109 medication ) , medication except antihypertensive agent . Subjects take antihypertensive drug least one week prior study . If subject blood pressure exceed 180/110 three determination period least 15 minute , subject withdrawn study appropriate antihypertensive therapy resume . Diabetic Subjects : Adults age 21 65 good general health except noninsulin dependent diabetes mellitus control oral hypoglycemic agent . Subjects medication . If fasting blood glucose exceed 300 mg/dl , subject withdrawn study appropriate therapy resume . EXCLUSION CRITERIA : Pregnancy , liver disease , pulmonary disease , endorgan damage renal insufficiency , coronary artery disease , heart failure , peripheral vascular disease , proliferative retinopathy , diabetic neuropathy , HIV infection .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 11, 2007</verification_date>
	<keyword>Insulin Resistance</keyword>
	<keyword>Obesity</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Mathematical Modeling</keyword>
	<keyword>Normal Volunteer</keyword>
</DOC>